🇺🇸 FDA

Intelligence · Clinical Pipeline

Phase II Pipeline Programs

Proof-of-concept and dose-finding clinical programs in Phase II development.

Programs
7,238

Quick answer

NovaPharmaNews tracks 7,238 phase ii pharmaceutical pipeline programs from ClinicalTrials.gov. Proof-of-concept and dose-finding clinical programs in Phase II development.

Top sponsors

Page 51 of 151

  1. FOLFOXIRI-based HAIC+Fuquinitinib

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Colorectal Neoplasms

    phase 2 small molecule completed

    1 trial

  2. FOLINATE DE CALCIUM HIKMA 10 mg/mL, solution injectable/pour perfusion, Oxaliplatin Kabi 5 mg/ml Konzentrat zur Herstellung einer Infusionslösung, S241656 film-coated tablet 50mg, Erbitux 5 mg/mL solution for infusion, Vectibix 20 mg/ml concentrate for solution for infusion, S241656 film-coated tablet 25mg, Gemcitabin Hikma 38 mg/ml Konzentrat zur Herstellung einer Infusionslösung, Bugvi 5 mg/ml pulbere pentru dispersie perfuzabilă, Irinotecan Kabi 20 mg/ml Konzentrat zur Herstellung einer Infusionslösung,

    The George Institute

    Malignancies with Documented KRAS, BRAF and Other Selected RAS/MAPK Mutations

    phase 2 small molecule active

    1 trial

  3. FOLINATE DE CALCIUM HIKMA 10 mg/mL, solution injectable/pour perfusion, Vectibix 20 mg/ml concentrate for solution for infusion, Fluorouracilo Accord 50 mg/ml solución inyectable o para perfusión EFG, Fluorouracil Accord 50 mg/ml Injektions-/ Infusionslösung, Fluorouracile AHCL 50 mg/ml, Soluzione per iniezione o infusione, SOTORASIB, FLUOROURACILE ACCORD 50 mg/ml, solution à diluer pour perfusion, Fluorouracilo Accord 50 mg/ml solución inyectable o para perfusión EFG, FLUOROURACILE ACCORD 50 mg/ml, solutio

    CERO THERAPEUTICS HOLDINGS, INC.

    colorectal cancer

    phase 2 small molecule active

    1 trial

  4. FOLINIC ACID, FLUOROURACIL, BEVACIZUMAB, Telisotuzumab adizutecan, FOLINIC ACID, PANITUMUMAB, OXALIPLATIN

    AbbVie Deutschland GmbH & Co. KG

    Metastatic Colorectal Cancer

    phase 2 small molecule active

    1 trial

  5. FORTRANS, poudre pour solution buvable en sachet., TOXICARB, suspension buvable

    Pari Pharma GmbH

    Major patients intoxicated by functional toxicant(s), hospitalized in intensive care and intubated.

    phase 2 small molecule active

    1 trial

  6. FP-1039

    Prime Medicine

    Endometrial Cancers With FGFR2 Mutations

    phase 2 small molecule terminated

    1 trial

  7. FP01

    Avalo Therapeutics

    Acute Cough

    phase 2 small molecule completed

    1 trial

  8. FP01

    Avalo Therapeutics

    Chronic Refractory Cough

    phase 2 small molecule completed

    1 trial

  9. FPA008

    Prime Medicine

    Pigmented Villonodular Synovitis

    phase 2 mab completed

    1 trial

  10. FRUZAQLA 5 mg hard capsules, FLUOROURACIL, FOLINIC ACID, FLUOROURACIL, IRINOTECAN, OXALIPLATIN, Avastin 25 mg/ml concentrate for solution for infusion., FRUZAQLA 1 mg hard capsules

    CERO THERAPEUTICS HOLDINGS, INC.

    métastatique colorectal cancer

    phase 2 small molecule active

    1 trial

  11. FRUZAQLA 5 mg hard capsules, Tevimbra 100 mg concentrate for solution for infusion, FRUZAQLA 1 mg hard capsules, Lonsurf 15 mg/6.14 mg film-coated tablets, Avastin 25 mg/ml concentrate for solution for infusion.

    The George Institute

    Metastatic Colorectal Cancer without liver metastases

    phase 2 small molecule active

    1 trial

  12. FRα peptide plus Adjuvant (GM-CSF)

    Marker Therapeutics

    Platinum Sensitive Ovarian Cancer

    phase 2 mab terminated

    1 trial

  13. FSD201

    Quantum Biopharma

    COVID-19

    phase 2 small molecule terminated

    1 trial

  14. FSD201

    Quantum Biopharma

    Mast Cell Activation Syndrome

    phase 2 small molecule terminated

    1 trial

  15. FST-100

    Takeda

    Acute Adenoviral Conjunctivitis

    phase 2 small molecule completed

    1 trial

  16. FST-100

    Takeda

    Acute Viral Conjunctivitis

    phase 2 small molecule completed

    1 trial

  17. FST-100 Ophthalmic Suspension

    Takeda

    Acute Adenoviral Conjunctivitis

    phase 2 small molecule terminated

    1 trial

  18. FT819

    Zafatek

    Lupus Nephritis

    phase 2 mab active

    1 trial

  19. FULVESTRANT, LETROZOLE

    Pfizer Australia Pty Ltd

    HR-positive HER2-negative metastatic/advanced BC

    phase 2 small molecule active

    1 trial

  20. FULVESTRANT, M1774 50mg, M1774 30mg

    The George Institute

    advanced breast cancer

    phase 2 small molecule active

    1 trial

  21. FULVESTRANT, camizestrant, camizestrant

    AstraZeneca AB

    Estrogen Receptor Positive HER2 Negative Advanced Breast Cancer

    phase 2 small molecule active

    1 trial

  22. FWD1802

    Forward Pharmaceuticals Co.,

    Metastatic Breast Cancer

    phase 2 small molecule active

    1 trial

  23. FWY003, FWY003, Placebo to FWY003, FWY003

    Novartis Pharmaceuticals

    Geographic atrophy secondary to age-related macular degeneration

    phase 2 small molecule active

    1 trial

  24. FX005

    Pacira Ireland Limited

    Osteoarthritis, Knee

    phase 2 small molecule completed

    1 trial

  25. FX006

    Pacira Ireland Limited

    Osteoarthritis of the Shoulder

    phase 2 small molecule terminated

    1 trial

  26. FX006

    Pacira Ireland Limited

    Trochanteric Bursitis

    phase 2 small molecule completed

    1 trial

  27. FX006 10 mg

    Pacira Ireland Limited

    Osteoarthritis of the Knee

    phase 2 small molecule completed

    2 trials

  28. FX006 32 mg

    Pacira Ireland Limited

    Post-traumatic Osteoarthritis of the Knee

    phase 2 small molecule terminated

    1 trial

  29. FX006 32 mg

    Pacira Ireland Limited

    Osteoarthritis, Hip

    phase 2 small molecule completed

    1 trial

  30. FX006 32 mg

    Pacira Ireland Limited

    Bilateral Knee Osteoarthritis

    phase 2 small molecule completed

    1 trial

  31. FX006 32 mg

    Pacira Ireland Limited

    Osteoarthritis of the Shoulder

    phase 2 small molecule completed

    1 trial

  32. Family Therapy based on Structural Family Therapy

    BRIGHT MINDS BIOSCIENCES INC.

    Substance Use Disorders

    phase 2 other completed

    1 trial

  33. Famitinib

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Non-Small Cell Lung Cancer (NSCLC)

    phase 2 small molecule on hold

    1 trial

  34. Famotidine

    United Therapeutics Europe Ltd

    2019 Novel Coronavirus Disease

    phase 2 small molecule terminated

    3 trials

  35. Fancalen

    Lacuna Pharma Pty Ltd

    Fanconi anemia (subtype A)

    phase 2 small molecule active

    1 trial

  36. Faropenem

    Hospital Authority, Hong Kong

    Pulmonary Tuberculosis

    phase 2 small molecule completed

    1 trial

  37. Fasedienol Nasal Spray - Placebo Nasal Spray

    Vistagen Therapeutics

    Social Anxiety Disorder

    phase 2 small molecule active

    1 trial

  38. Fasiglifam

    Takeda

    Type 2 Diabetes Mellitus

    phase 2 small molecule terminated

    2 trials

  39. Faslodex 250 mg solution for injection., PALBOCICLIB, PALBOCICLIB, PALBOCICLIB, PALBOCICLIB, PALBOCICLIB, PALBOCICLIB

    Ningbo Cancer Hospital

    Metastatic breast cancer

    phase 2 small molecule active

    1 trial

  40. Favipiravir

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Influenza, Human

    phase 2 small molecule completed

    1 trial

  41. Fazisiran Injection

    Arrowhead Pharmaceuticals Ireland Limited

    Alpha 1-Antitrypsin Deficiency

    phase 2 small molecule completed

    1 trial

  42. Febuxostat

    Takeda

    Joint Damage

    phase 2 small molecule completed

    1 trial

  43. Febuxostat

    Takeda

    Renal Impairment

    phase 2 small molecule completed

    1 trial

  44. Febuxostat

    Takeda

    Hypertension

    phase 2 small molecule completed

    1 trial

  45. Febuxostat

    Takeda

    Hyperuricosuria

    phase 2 small molecule completed

    1 trial

  46. Febuxostat

    Takeda

    Angina

    phase 2 small molecule terminated

    1 trial

  47. Fecal microbiota transplantation (FMT)

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Slow Transit Constipation

    phase 2 small molecule active

    1 trial

  48. Felzartamab

    Biogen

    Immunoglobulin A (IgA) Nephropathy

    phase 2 small molecule completed

    1 trial

Frequently asked questions

How many Phase II pipeline programs are in the directory?

7,238 published programs match this development stage in our ClinicalTrials.gov index.

What defines this pipeline stage?

Phase and status reflect ClinicalTrials.gov registry fields at last sync. See our clinical trial phases reference for methodology.

Data attribution: Data sources · All pipeline programs

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.